Summary
Merck & Co., Inc. (MRK) filed an 8-K on January 29, 2007, primarily to furnish a press release and supplemental financial data regarding Schering-Plough's fourth quarter and full-year 2006 financial results. Investors should note that this filing pertains to Schering-Plough, not directly to Merck's own results for that period, although Merck was involved in a significant strategic transaction with Schering-Plough around this time (the planned acquisition of Merck's consumer care business by Schering-Plough). The provided information details Schering-Plough's performance, which could have implications for Merck given their business relationship and ongoing strategic activities.
Key Highlights
- 1The 8-K filing includes a press release from Schering-Plough reporting its financial results for the fourth quarter and full year of 2006.
- 2Supplemental financial data from Schering-Plough for the same periods is also provided as an exhibit.
- 3The filing is furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
- 4Investors are directed to Exhibits 99.1 and 99.2 for the detailed financial information from Schering-Plough.
- 5This filing is a routine submission to provide public access to Schering-Plough's reported financial outcomes.
- 6The information's relevance to Merck investors stems from the strategic partnership and transaction activities between Merck and Schering-Plough.